Literature DB >> 12543887

Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis.

Hidekatsu Fukuta1, Junichiro Hayano, Shinji Ishihara, Seiichiro Sakata, Seiji Mukai, Nobuyuki Ohte, Kazuhito Ojika, Keiko Yagi, Hiroko Matsumoto, Sinken Sohmiya, Genjiro Kimura.   

Abstract

BACKGROUND: Although decreased heart rate variability (HRV) is an independent predictor of death in various populations, its prognostic value in patients with end-stage renal disease on chronic haemodialysis is unknown.
METHODS: We prospectively studied 120 chronic haemodialysis patients (age 61+/-11 years; males 51%; diabetics 38%; duration of haemodialysis therapy 50+/-114 months) who underwent 24 h electrocardiography at baseline for analysis of time- and frequency-domain HRV.
RESULTS: All HRV measures in the patients were significantly reduced compared with those obtained from 62 age-matched healthy subjects. During a follow-up period of 26+/-10 months, 21 patients died (17.5%); 10 from cardiac causes and 11 from non-cardiac causes (seven fatal strokes and four other causes). A Cox proportional hazards model revealed that, of the HRV measures, decreases in the triangular index (TI), very-low-frequency (0.0033-0.04 Hz) power, ultra-low-frequency (<0.0033 Hz) power (ULF) and the ratio of low-frequency (0.04-0.15 Hz) power to high-frequency (0.15-0.4 Hz) power had significant predictive value for cardiac death. None of the HRV measures, however, had predictive value for non-cardiac death, including stroke death. Even after adjustment for other univariate predictors including age, diabetes, serum albumin and coronary artery disease, the predictive value of decreased TI and ULF remained significant-adjusted relative risk (95% confidence interval) per 1 SD decrement of TI and ULF, 3.28 (1.08-9.95) and 1.92 (1.01-3.67), respectively.
CONCLUSIONS: Decreases in some HRV measures, particularly those reflecting long-term variability, are independent predictors of cardiac death in chronic haemodialysis patients.

Entities:  

Mesh:

Year:  2003        PMID: 12543887     DOI: 10.1093/ndt/18.2.318

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  53 in total

Review 1.  Sudden cardiac death in end stage renal disease: unlocking the mystery.

Authors:  D Zachariah; P R Kalra; Paul R Roberts
Journal:  J Nephrol       Date:  2014-11-13       Impact factor: 3.902

2.  Impact of shock wave lithotripsy on heart rate variability in patients with urolithiasis.

Authors:  Wu-Chou Lin; Chien-Yi Ho; Yung-Hsiang Chen; I-Cheng Chen; Huey-Yi Chen; Fuu-Jen Tsai; Jui-Lung Shen; Samantha Shan Man; Po-Hsun Huang; Yuh-Lien Chen; Kee-Ming Man; Wen-Chi Chen
Journal:  Urol Res       Date:  2010-10-06

3.  Nonlinear measures of heart rate variability and mortality risk in hemodialysis patients.

Authors:  Mari Suzuki; Takahashi Hiroshi; Toru Aoyama; Miho Tanaka; Hideki Ishii; Masaya Kisohara; Narushi Iizuka; Toyoaki Murohara; Junichiro Hayano
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-21       Impact factor: 8.237

4.  Prognostic Value of Heart Rate Variability in Patients With Cancer.

Authors:  Ying Guo; Shalini Koshy; David Hui; J Lynn Palmer; Ki Shin; Mehtap Bozkurt; Syed Wamique Yusuf
Journal:  J Clin Neurophysiol       Date:  2015-12       Impact factor: 2.177

5.  Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients.

Authors:  Manuela Ferrario; Jochen G Raimann; Brett Larive; Andreas Pierratos; Stephan Thijssen; Sanjay Rajagopalan; Tom Greene; Sergio Cerutti; Gerald Beck; Christopher Chan; Peter Kotanko
Journal:  Blood Purif       Date:  2015-07-04       Impact factor: 2.614

6.  Autonomic effects on the spectral analysis of heart rate variability after exercise.

Authors:  Jason Ng; Sri Sundaram; Alan H Kadish; Jeffrey J Goldberger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-31       Impact factor: 4.733

7.  Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study.

Authors:  Ranjani N Moorthi; Simit Doshi; Linda F Fried; Sharon M Moe; Mark J Sarnak; Suzanne Satterfield; Ann V Schwartz; Michael Shlipak; Brittney S Lange-Maia; Tamara B Harris; Anne B Newman; Elsa S Strotmeyer
Journal:  Nephrol Dial Transplant       Date:  2019-04-01       Impact factor: 5.992

Review 8.  Prognostic significance and therapeutic option of heart rate variability in chronic kidney disease.

Authors:  Jing Zhang; Ningning Wang
Journal:  Int Urol Nephrol       Date:  2013-03-29       Impact factor: 2.370

9.  Heart rate variability and length of survival in hospice cancer patients.

Authors:  Do Hoon Kim; Jeong A Kim; Youn Seon Choi; Su Hyun Kim; June Young Lee; Young Eun Kim
Journal:  J Korean Med Sci       Date:  2010-07-21       Impact factor: 2.153

10.  Electrocardiogram abnormalities and heart rate variability in predicting mortality and cardiovascular events among hemodialyzed patients.

Authors:  Silvia Badarau; Dimitrie Siriopol; Daniela Drugus; Raluca Dumea; Simona Hogas; Mihaela Blaj; Luminita Voroneanu; Angelica Gramaticu; Antoniu Petris; Alexandru Burlacu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.